Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy Breadcrumbs UL Home Research Publications Year of Publication 2018 Journal Jco Precision Oncology DOI 10.1200/PO.17.00241